SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarey Drugs strengthens on securing first commercial export order

09 May 2017 Evaluate

Aarey Drugs & Pharmaceuticals is currently trading at Rs. 107.00, up by 2.40 points or 2.29% from its previous closing of Rs. 104.60 on the BSE.

The scrip opened at Rs. 108.00 and has touched a high and low of Rs. 108.00 and Rs. 105.00 respectively. So far 98435 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 109.80 on 28-Apr-2017 and a 52 week low of Rs. 36.00 on 10-May-2016.

Last one week high and low of the scrip stood at Rs. 108.80 and Rs. 101.10 respectively. The current market cap of the company is Rs. 193.42 crore.

The promoters holding in the company stood at 53.40%, while Non-Institutions held 46.60% stake in the company.

Aarey Drugs & Pharmaceuticals has received its first commercial export order for 20 metric tones of Thiobromine from Germany. The order will be executed by June 30, 2017. 

Aarey Drugs & Pharmaceuticals is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Aarey Drugs & Pharma Share Price

82.15 3.47 (4.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×